Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

56.12
-1.3100-2.28%
Post-market: 56.120.00000.00%19:34 EDT
Volume:2.92M
Turnover:163.64M
Market Cap:13.91B
PE:17.65
High:57.43
Open:56.76
Low:54.55
Close:57.43
52wk High:59.72
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:1.48
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.54
PE(LYR):20.19

Loading ...

FDA-Driven Zanza Delay Keeps Exelixis Fairly Valued, Supporting Willey’s Hold Rating

TIPRANKS
·
Yesterday

Analysts’ Opinions Are Mixed on These NA Stocks: SpaceX (SPCX), Insmed (INSM) and Exelixis (EXEL)

TIPRANKS
·
Yesterday

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12

Exelixis risk of rejection ‘low’ despite zanzalintinib delay, says William Blair

TIPRANKS
·
Sep 12

Analysts Offer Insights on NA Companies: Exelixis (EXEL) and HEICO (HEI)

TIPRANKS
·
Sep 11

Exelixis Shares Fall 3% After US FDA Extends Review of Co's Cancer Drug

THOMSON REUTERS
·
Sep 11

U.S. FDA Extends Review of Exelixis' Cancer Drug

Reuters
·
Sep 11

Exelixis - FDA Extends Review Period for Exelixis Nda for Zanzalintinib and Atezolizumab by Three Months - SEC Filing

THOMSON REUTERS
·
Sep 11

Adagene Receives Milestone Payment From Exelixis

MT Newswires Live
·
Sep 09

Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration

TIPRANKS
·
Sep 09

Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program

Reuters
·
Sep 09

Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment

Reuters
·
Sep 09

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

GlobeNewswire
·
Sep 09

EXEL Industries Updates Share Capital and Voting Rights for August 2026

TIPRANKS
·
Sep 03

Exelixis to Webcast Fireside Chats at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Exelixis Secures Key Patent Victory, Extends Exclusivity

TIPRANKS
·
Sep 01

Exelixis Wins Appeal in Patent Case Against MSN Laboratories

MT Newswires Live
·
Sep 01

Exelixis says appeals court affirmed ‘key portion’ of 2024 judgment

TIPRANKS
·
Sep 01

Exelixis Wins Federal Circuit Ruling Upholding Cabometyx Crystalline Salt Patents

Reuters
·
Sep 01

Exelixis - U.S. Court of Appeals for the Federal Circuit Affirms Key Portion of 2024 Judgment in Exelixis' Favor

THOMSON REUTERS
·
Sep 01